Key Financial Data Of Group

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7298504

Concept As at
2024-09-30
2024-04-01 to
2024-09-30
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2023-09-30
2023-04-01 to
2023-09-30
Key financial data of group
Business results of group
Net sales
51,372,000,000 JPY
72,044,000,000 JPY
36,171,000,000 JPY
Ordinary profit (loss)
19,823,000,000 JPY
9,951,000,000 JPY
5,722,000,000 JPY
Profit (loss) attributable to owners of parent
14,286,000,000 JPY
8,025,000,000 JPY
4,068,000,000 JPY
Comprehensive income
13,469,000,000 JPY
11,684,000,000 JPY
5,814,000,000 JPY
Net assets
154,405,000,000 JPY
143,755,000,000 JPY
140,728,000,000 JPY
Total assets
187,123,000,000 JPY
171,623,000,000 JPY
171,651,000,000 JPY
Basic earnings (loss) per share
377.23
212.67
108.18
Diluted earnings per share
Equity-to-asset ratio
0.825 xbrli:pure
0.838 xbrli:pure
0.820 xbrli:pure
Net cash provided by (used in) operating activities
23,932,000,000 JPY
2,577,000,000 JPY
-245,000,000 JPY
Net cash provided by (used in) investing activities
-2,432,000,000 JPY
-5,854,000,000 JPY
-1,141,000,000 JPY
Net cash provided by (used in) financing activities
-2,839,000,000 JPY
-5,658,000,000 JPY
-2,813,000,000 JPY
Cash and cash equivalents
83,987,000,000 JPY
65,325,000,000 JPY
70,060,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.